Effectiveness of an Autologous Micrografting Technology for Treating Stretch Marks
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Andrea Garelli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Medicine, University Tor Vergata, Rome, Italy. Hauptthemen laut MEDLINE: Striae Distensae, Cosmetic Techniques. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Stretch marks or striae distensae (SD) are common dermal lesions caused by the disruption of collagen and elastin fibers in the skin, often triggered by rapid mechanical stretching. Despite the availability of numerous treatment modalities, from topical agents to energy‐based devices, no single therapy has demonstrated consistent, long‐term efficacy across all patient populations. The pathophysiology of SD involves complex alterations in the extracellular matrix (ECM), particularly affecting fibroblast activity and collagen/elastin synthesis.
Aims
This pilot study aims to evaluate the clinical and molecular efficacy of autologous micrografting technology as a novel therapeutic option for SD. Specifically, it investigates the treatment's impact on ECM‐related gene expression and overall skin appearance. Patients/Methods Fourteen patients (13 females, 1 male) with clinically evident SD were enrolled. All participants underwent a standardized treatment protocol comprising microneedling followed by intradermal injection of autologous micrografts, obtained via a minimally invasive procedure. Clinical assessments were performed through standardized photography at baseline, 1 month, and 6 months post‐treatment. In vitro assays were conducted on cultured human dermal fibroblasts exposed to the micrograft suspension.
Results
Clinical evaluations showed noticeable aesthetic improvements, including reduced striae visibility and improved skin texture, with high patient‐reported satisfaction. Molecular analyses revealed the upregulation of key ECM genes, including COL4A1, COL6A1, and ELN, indicating enhanced fibroblast activation and regenerative potential.
Conclusions
Autologous micrografting appears to be a promising, biologically active approach for SD treatment. It promotes ECM remodeling by stimulating fibroblast function and may represent a valuable addition to the therapeutic landscape for stretch marks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Systems Medicine, University Tor Vergata, Rome, Italy.
- Department Chemistry, Biology, Biotechnology, University of Perugia, Perugia, Italy.
- SHRO Italia Foundation ETS, Candiolo, (TO), Italy.
- Exel Poliambulatorio, Monza, Italy.
- Lazerhous Clinic, Kiev, Ukraine.
- Division of Dermatology, Department, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Zitieren
APA
Garelli, A., Pessei, V., Tagliabue, R., Sles, O., & Panchaprateep, R. (2025). Effectiveness of an Autologous Micrografting Technology for Treating Stretch Marks. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70321
Vancouver
Garelli A, Pessei V, Tagliabue R, Sles O, Panchaprateep R. Effectiveness of an Autologous Micrografting Technology for Treating Stretch Marks. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70321
BibTeX
@article{Garelli2025,
author = {Garelli, Andrea and Pessei, Valeria and Tagliabue, Ruggero and Sles, Olha and Panchaprateep, Ratchathorn},
title = {Effectiveness of an Autologous Micrografting Technology for Treating Stretch Marks},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70321}
}
EUVIMED